| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARAV | Aravive, Inc. | McIntyre Gail Frances | CEO and President | Oct 24, 2022 | Option Exercise | $0.92 | 54,353 | 49,999 | 65,490 | Oct 26, 2022, 05:01 PM | |
| ARAV | Aravive, Inc. | McIntyre Gail Frances | CEO and President | Dec 04, 2020 | Buy | $5.77 | 8,000 | 46,160 | 10,137 | Dec 07, 2020, 08:00 PM | |
| FURX | Furiex Pharmaceuticals, Inc. | McIntyre Gail Frances | Senior Vice President-Research | Jun 16, 2014 | Option Exercise | $59.77 | 129,094 | 7,716,481 | 57,246 | Jun 18, 2014, 04:46 PM | |
| FURX | Furiex Pharmaceuticals, Inc. | McIntyre Gail Frances | Senior Vice President-Research | Jun 17, 2014 | Option Exercise | $59.08 | 16,016 | 946,225 | 32,326 | Jun 18, 2014, 04:46 PM | |
| FURX | Furiex Pharmaceuticals, Inc. | McIntyre Gail Frances | Senior Vice President-Research | Jun 10, 2014 | Sale | $104.58 | 1,746 | 182,597 | 28,122 | Jun 12, 2014, 05:09 PM | |
| FURX | Furiex Pharmaceuticals, Inc. | McIntyre Gail Frances | Senior Vice President-Research | Jul 19, 2013 | Sale | $40.00 | 20,000 | 800,000 | 17,868 | Sep 18, 2013, 09:43 PM | |
| FURX | Furiex Pharmaceuticals, Inc. | McIntyre Gail Frances | Senior Vice President-Research | Jul 19, 2013 | Sale | $24.55 | 40,000 | 982,200 | 37,868 | Jul 23, 2013, 09:24 PM | |
| FURX | Furiex Pharmaceuticals, Inc. | McIntyre Gail Frances | Senior Vice President-Research | Nov 17, 2011 | Buy | $16.89 | 6,500 | 109,785 | 6,768 | Nov 21, 2011, 05:23 PM |
Menu